News

Invitrogen will combine its Voltage Sensor Probes ion channel reagents with PerkinElmer’s CellLux™ Fluorescence Cellular Screening Platform.

This patent family, owned by Alnylam, covers small interfering RNAs and their use to mediate RNAi in mammalian cells.

GenomeQuest™ is a genomic information service and software application that provides sequence comparison solutions for biological and patent investigators.

ULS™ is now the preferred labeling method for both bacterial gene expression profiling and Chip on Chip assays that have been developed at the ISB.

Sequenom's iPLEX assay is very useful for evaluating targeted sets of SNPs and also expedites follow up work in the validation of genome scan results.

Researchers have discovered a set of simple rules and have now employed these rules to create artificial proteins.

Sareum will utilise its skills in high throughput protein expression, purification and structure determination to illustrate the precise nature of how Infinity’s potential drug candidates interact with target receptor proteins.

Power3 Medical Products, Inc. has discovered a group of breast cancer protein biomarkers in preliminary studies of blood serum.

This patent establishes protection around the company's innovative linear, isothermal RNA amplification technology.

Agreement strengthens febit’s IP and places febit in a position to successfully market Geniom® worldwide.